IQVIA Holdings has recently seen its consensus analyst price target rise significantly, climbing from $223.42 to $246.84.

The change in ownership is noted in a single sentence on the “About” page on Throtle’s website: “Throtle Inc. is a wholly owned subsidiary of IQVIA Inc., operating as an independent unit within IQVIA ...

Demand for AI pros among non-tech firms rose 25-50% compared to last year, say hiring firms. The demand for AI jobs is mostly for engineering, support and functional roles, according to data collated ...

Detailed price information for Iqvia Holdings Inc (IQV-N) from The Globe and Mail including charting and trades.

Detailed price information for Iqvia Holdings Inc (IQV-N) from The Globe and Mail including charting and trades.

IQVIA's third quarter results reflected stable operational execution, with revenue and profit slightly ahead of Wall Street ...

Steve will be monitoring the Rapid Fires: AI/ML in Bioanalysis session on Monday, Nov. 10, 2025 at 3PM CT at AAPS PharmSci ...

To learn more about how method validation is performed for biomarker bioanalysis, Pharmaceutical Technology ® spoke with ...

While the top- and bottom-line numbers for IQVIA (IQV) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare ...

Among the most significant challenges facing the healthcare industry are rising costs, the aging population and the shrinking healthcare workforce. On top of that, policy changes are putting pressure ...

IQVIA Holdings Inc. ( IQV) UBS Global Healthcare Conference 2025 November 11, 2025 12:30 PM EST All right. We're live. Next up, we have IQVIA. Representing IQVIA is Ari Bousbib. Ari, welcome. Thank ...

Stock selection in communication services, consumer discretionary and health care drove underperformance during the quarter. Read more here.